ask="2.50"
ask_size="1300"
average_daily_volume="89876"
bid="1.81"
bid_size="3500"
book_value="1.40"
change="-0.04"
change_from_200_day_moving_average="1.08"
change_from_50_day_moving_average="0.82"
change_from_52_week_high="-2.66"
change_From_52_week_low="1.53"
change_in_percent="-1.92%"
close="2.04"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.30"
ebitda="-2.11M"
eps_estimate_current_year="-0.02"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="-0.02"
ex_dividend_date="N/A"
float_shares="1824000"
high="2.09"
high_52_weeks="4.70"
last_trade_date="2/24/2017"
last_trade_price="2.04"
last_trade_size="500"
last_trade_time="4:00pm"
low="1.99"
low_52_weeks="0.51"
market_capitalization="5.47M"
moving_average_200_day="0.96"
moving_average_50_day="1.22"
name="XTL Biopharmaceuticals Ltd. - A"
notes="N/A"
one_year_target_price="30.00"
open="2.07"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+113.35%"
percent_change_from_50_day_moving_average="+67.05%"
percent_change_from_52_week_high="-56.60%"
percent_change_from_52_week_low="+300.00%"
previous_close="2.08"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.49"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="2680000"
short_ratio="0.12"
stock_exchange="NCM"
symbol="XTLB"
volume="40958"
weeks_range_52="0.51 - 4.70"
